Table 4 Classification of 48 validation set patients into risk groups based on the commercial and RUO EP scores.
Commercial EP (RT-PCR) | RUO EP (NanoString-derived) data | Total | |
|---|---|---|---|
Low | High | ||
Low | 17 | 3 | 20 |
High | 0 | 28 | 28 |
Total | 17 | 31 | 48 |
Commercial EP (RT-PCR) | RUO EP (NanoString-derived) data | Total | |
|---|---|---|---|
Low | High | ||
Low | 17 | 3 | 20 |
High | 0 | 28 | 28 |
Total | 17 | 31 | 48 |
